Literature DB >> 17433841

Gamma-delta T-cell-mediated dilated cardiomyopathy.

Norifumi Takeda, Yoshinori Seko, Noboru Oriuchi, Ryozo Nagai.   

Abstract

Gamma-delta T-cells are usually minor component of peripheral blood and lymphoid tissues, but may play an important role in autoimmune diseases. We here describe the first case of dilated cardiomyopathy (DCM) with heart infiltration by mostly gamma-delta T-cells, who improved significantly by steroid therapy. In general, steroid therapy has only a little effect on DCM, however these findings might have implications with respect to the selection of patients who might respond to immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17433841     DOI: 10.1016/j.ijcard.2007.01.068

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  Cell autonomous role of iASPP deficiency in causing cardiocutaneous disorders.

Authors:  Zinaida Dedeić; Gopinath Sutendra; Ying Hu; Kathryn Chung; Elizabeth A Slee; Michael J White; Felix Y Zhou; Robert D Goldin; David J P Ferguson; Debra McAndrew; Jurgen E Schneider; Xin Lu
Journal:  Cell Death Differ       Date:  2018-01-19       Impact factor: 15.828

Review 2.  Cross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response.

Authors:  Wei Liu; Sally A Huber
Journal:  Virol J       Date:  2011-01-21       Impact factor: 4.099

3.  Sequence variation in PPP1R13L results in a novel form of cardio-cutaneous syndrome.

Authors:  Tzipora C Falik-Zaccai; Yiftah Barsheshet; Hanna Mandel; Meital Segev; Avraham Lorber; Shachaf Gelberg; Limor Kalfon; Shani Ben Haroush; Adel Shalata; Liat Gelernter-Yaniv; Sarah Chaim; Dorith Raviv Shay; Morad Khayat; Michal Werbner; Inbar Levi; Yishay Shoval; Galit Tal; Stavit Shalev; Eli Reuveni; Emily Avitan-Hersh; Eugene Vlodavsky; Liat Appl-Sarid; Dorit Goldsher; Reuven Bergman; Zvi Segal; Ora Bitterman-Deutsch; Orly Avni
Journal:  EMBO Mol Med       Date:  2017-03       Impact factor: 12.137

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.